Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,266 | 0 | 0 | 0 | 11,432 |
| Receivables | 3,226 | 0 | 0 | 0 | 3,908 |
| Other current assets | 0 | 0 | 0 | 0 | 909 |
| TOTAL | $47,901 | $0 | $0 | $0 | $16,249 |
| Non-Current Assets | |||||
| PPE Net | 629 | N/A | N/A | N/A | 768 |
| Other Non-Current Assets | 2,136 | 0 | 0 | 0 | 0 |
| TOTAL | $2,765 | $N/A | $N/A | $N/A | $768 |
| Total Assets | $50,666 | $0 | $0 | $0 | $19,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,667 | 0 | 0 | 0 | 3,889 |
| Accrued Expenses | 2,537 | 0 | 0 | 0 | 1,421 |
| Other current liabilities | N/A | 0 | 0 | 0 | 270 |
| TOTAL | $7,641 | $0 | $0 | $0 | $5,752 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 245 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 80,007 | -42 | 69 | 130 | 33,765 |
| TOTAL | $79,937 | $N/A | $N/A | $N/A | $33,765 |
| Total Liabilities | $87,578 | $0 | $0 | $0 | $41,122 |
| Shareholders' Equity | |||||
| Retained earnings | -57,720 | 0 | 0 | 0 | -37,885 |
| Other shareholders' equity | -852 | 0 | 0 | 0 | -100 |
| TOTAL | $-36,912 | $0 | $0 | $0 | $-22,079 |
| Total Liabilities And Equity | $50,666 | $0 | $0 | $0 | $19,043 |